Vitamin D activation and function in human corneal epithelial cells during TLR-induced inflammation

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 13, 2015, Pages 7715-7727

  Reins, Rose Yvonne ^a   Baidouri, Hasna ^a   McDermott, Alison Marie ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Antimicrobial; Cornea; Inflammation; Toll like receptors; Vitamin D

Indexed keywords

BETA DEFENSIN 2; CALCITRIOL; CATHELICIDIN; CD14 ANTIGEN; COLECALCIFEROL 24 HYDROXYLASE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORNEA EPITHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMORTALIZED CELL LINE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; KERATITIS; LUMINEX ASSAY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RADIOIMMUNOPRECIPITATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CADAVER; CELL CULTURE; CORNEA; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; METABOLISM; PATHOLOGY;

CADAVER; CALCITRIOL; CELLS, CULTURED; CORNEA; EPITHELIAL CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; TOLL-LIKE RECEPTORS; VITAMIN D;

EID: 84950335900     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-17768     Document Type: Article

References (78)

1. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76:3837-3843.
2. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med. 2010;88:441-450.
3. Schauber J, Gallo RL. The vitamin D pathway: a new target for control of the skin’s immune response? Exp Dermatol. 2008; 17:633-639.
4. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726-776.
5. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004;29:664-673.
6. Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. J Lipid Res. 2014;55:13-31.
7. Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys. 2012;523:95-102.
8. Kim S, Shevde NK, Pike JW. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res. 2005;20:305-317.
9. Haussler MR, Jurutka PW, Hsieh JC, et al. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 1995;17:33S-38S.
10. Tang J, Zhou R, Luger D, et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol. 2009;182:4624-4632.
11. Albert DM, Marcus DM, Gallo JP, O’Brien JM. The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma. Invest Ophthalmol Vis Sci. 1992;33:2354-2364.
12. Audo I, Darjatmoko SR, Schlamp CL, et al. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci. 2003;44: 4192-4199.
13. Shokravi MT, Marcus DM, Alroy J, Egan K, Saornil MA, Albert DM. Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci. 1995;36:83-87.
14. Mano T, Puro DG. Phagocytosis by human retinal glial cells in culture. Invest Ophthalmol Vis Sci. 1990;31:1047-1055.
15. Morrison MA, Silveira AC, Huynh N, et al. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 2011;5:538-568.
16. Singh A, Falk MK, Subhi Y, Sørensen TL. The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One. 2013;8:e70948.
17. Graffe A, Milea D, Annweiler C, et al. Association between hypovitaminosis D and late stages of age-related macular degeneration: a case-control study. J Am Geriatr Soc. 2012;60: 1367-1369.
18. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol. 2007;125:661-669.
19. Graffe A, Beauchet O, Fantino B, Milea D, Annweiler C. Vitamin d and macular thickness in the elderly: an optical coherence tomography study. Invest Ophthalmol Vis Sci. 2014;55:5298-5303.
20. Millen AE, Voland R, Sondel SA, et al. CAREDS Study Group. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol. 2011;129:481-489.
21. Mutti DO, Marks AR. Blood levels of vitamin D in teens and young adults with myopia. Optom Vis Sci. 2011;88:377-382.
22. Choi JA, Han K, Park Y-M, La TY. Low serum 25-hydroxyvitamin D is associated with myopia in Korean adolescents. Invest Ophthalmol Vis Sci. 2014:55:2041-2047.
23. Yazar S, Hewitt AW, Black LJ, et al. Myopia is associated with lower vitamin D status in young adults. Invest Ophthalmol Vis Sci. 2014;55:4552-4559.
24. Lee V, Rekhi E, Hoh Kam J, Jeffery G. Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol Aging. 2012;33: 2382-2389.
25. Kutuzova GD, Gabelt BT, Kiland JA, Hennes-Beann EA, Kaufman PL, DeLuca HF. 1a,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1a,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates. Arch Biochem Biophys. 2012;518:53-60.
26. Lin Y, Ubels JL, Schotanus MP, et al. Enhancement of vitamin D metabolites in the eye following vitamin D3 supplementation and UV-B irradiation. Curr Eye Res. 2012;37:871-878.
27. Yin Z, Pintea V, Lin Y, Hammock BD, Watsky MA. Vitamin D enhances corneal epithelial barrier function. Invest Ophthal- mol Vis Sci. 2011;52:7359-7364.
28. Johnson JA, Grande JP, Roche PC, Campbell RJ, Kumar R. Immuno-localization of the calcitriol receptor, calbindin-D28k and the plasma membrane calcium pump in the human eye. Curr Eye Res. 1995;14:101-108.
29. Alsalem JA, Patel D, Susarla R, et al. Characterization of vitamin d production by human ocular barrier cells. Invest Ophthalmol Vis Sci. 2014;55:2140-2147.
30. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
31. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87: 1080S-1086S.
32. Wang T-T, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909-2912.
33. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte- derived dendritic cells. J Immunol. 2000;164:4443-4451.
34. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(þ) T cells to enhance the development of Th2 cells. J Immunol. 2001;167:4974-4980.
35. Gambhir V, Kim J, Siddiqui S, et al. Influence of 1,25-dihydroxy vitamin D3 on TLR4-induced activation of antigen presenting cells is dependent on the order of receptor engagement. Immunobiology. 2011;216:988-996.
36. Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporespon-siveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36:361-370.
37. Khoo A-L, Chai LYA, Koenen HJPM, et al. Vitamin D(3) down-regulates proinflammatory cytokine response to Mycobacteri-um tuberculosis through pattern recognition receptors while inducing protective cathelicidin production. Cytokine. 2011; 55:294-300.
38. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394-397.
39. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376.
40. Moeenrezakhanlou A, Nandan D, Reiner NE. Identification of a calcitriol-regulated Sp-1 site in the promoter of human CD14 using a combined western blotting electrophoresis mobility shift assay (WEMSA). Biol Proced Online. 2008;10:29-35.
41. Shin D-M, Yuk J-M, Lee H-M, et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol. 2010;12:1648-1665.
42. Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporespon- siveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36:361-370.
43. Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehen-sive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012;280:22-35.
44. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75:39-48.
45. Huang LC, Petkova TD, Reins RY, Proske RJ, McDermott AM. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci. 2006;47:2369-2380.
46. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun. 1995;63:1291-1297.
47. Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, Gold MR. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol. 2000;164:549-553.
48. Mookherjee N, Brown KL, Bowdish DME, et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol. 2006;176: 2455-2464.
49. Lande R, Gregorio J, Facchinetti V, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007;449:564-569.
50. Ganguly D, Chamilos G, Lande R, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009;206:1983-1994.
51. Nijnik A, Pistolic J, Wyatt A, Tam S, Hancock REW. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. J Immunol. 2009;183:5788-5798.
52. Yu J, Mookherjee N, Wee K, et al. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol. 2007; 179:7684-7691.
53. McDermott AM. Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf. 2004;2:229-247.
54. Gordon YJ, Huang LC, Romanowski EG, Yates KA, Proske RJ, McDermott AM. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res. 2005; 30:385-394.
55. McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ. Defensin expression by the cornea: multiple signaling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:1859-1865.
56. Pei Y, Reins RY, McDermott AM. Aldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes. Exp Eye Res. 2006;83:1063-1073.
57. Robertson DM, Li L, Fisher S, et al. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci. 2005; 46:470-478.
58. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
59. Redfern RL, Reins RY, McDermott AM. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells. Exp Eye Res. 2011;92:209-220.
60. Kumar A, Zhang J, Yu F-SX Toll-like receptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells. Microbes Infect. 2006;8:380-389.
61. Larriba MJ, González-Sancho JM, Bonilla F, Muñoz A. Interaction of vitamin D with membrane-based signaling pathways. Front Physiol. 2014;5:60.
62. Jeong S, Ledee DR, Gordon GM, et al. Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation. Am J Pathol. 2012; 180:2028-2039.
63. Li D-Q, Pflugfelder SC. Matrix metalloproteinases in corneal inflammation. Ocul Surf. 2005;3:S198-S202.
64. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689S-1696S.
65. Kumar R, Iachini DN, Neilsen PM, et al. Systematic character-isation of the rat and human CYP24A1 promoter. Mol Cell Endocrinol. 2010;325:46-53.
66. Schuster I. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta. 2011; 1814:186-199.
67. Jones G, Prosser DE, Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys. 2012;523:9-18.
68. Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009;4:e5810.
69. Peric M, Koglin S, Kim S-M, et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol. 2008;181:8504-8512.
70. Peric M, Koglin S, Dombrowski Y, et al. Vitamin D analogs differentially control antimicrobial peptide/‘‘alarmin’’ expres- sion in psoriasis. PLoS One. 2009;4:e6340.
71. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770-1773.
72. Schauber J, Dorschner RA, Coda AB, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007;117: 803-811.
73. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008;181:7090-7099.
74. Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59:881-886.
75. Suzuki T, Sano Y, Kinoshita S. Effects of 1alpha,25-dihydrox-yvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. Invest Ophthalmol Vis Sci. 2000; 41:154-158.
76. Dang S-T, Lu X-H, Zhou J, Bai L. Effects of 1alpha, 25-dihydroxyvitamin D3 on the acute immune rejection and corneal neovascularization in high-risk penetrating keratoplasty in rats [in Chinese]. 1 Jun Yi Xue Xue Bao. 2004;24:892-896.
77. Suzuki T, Sano Y, Sotozono C, Kinoshita S. Regulatory effects of 1alpha,25-dihydroxyvitamin D(3) on cytokine production by human corneal epithelial cells. Curr Eye Res. 2000;20:127-130.
78. Xue M-L, Zhu H, Thakur A, Willcox M. 1 alpha,25-Dihydrox-yvitamin D3 inhibits pro-inflammatory cytokine and chemo-kine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunol Cell Biol. 2002;80: 340-345.